Biology of Sexual Dysfunction

MN, Anil Kumar and Pai, NB and Rao, S and Rao, TSS and Goyal, N (2009) Biology of Sexual Dysfunction. [Journal (On-line/Unpaginated)]

Full text available as:

PDF - Published Version
Available under License Creative Commons Attribution No Derivatives.



Sexual activity is a multifaceted activity, involving complex interactions between the nervous system, the endocrine system, the vascular system and a variety of structures that are instrumental in sexual excitement, intercourse and satisfaction. Sexual function has three components i.e., desire, arousal and orgasm. Many sexual dysfunctions can be categorized according to the phase of sexual response that is affected. In actual clinical practice however, sexual desire, arousal and orgasmic difficulties more often than not coexist, suggesting an integration of phases. Sexual dysfunction can result from a wide variety of psychological and physiological causes including derangements in the levels of sex hormones and neurotrensmitters. This review deals with the biology of different phases of sexual function as well as implications of hormones and neurotransmitters in sexual dysfunction

Item Type:Journal (On-line/Unpaginated)
Keywords:Sexual dysfunction, Hormones, Neurotransmitters
Subjects:JOURNALS > Online Journal of Health and Allied Sciences
ID Code:6557
Deposited By: Kakkilaya Bevinje, Dr. Srinivas
Deposited On:02 Jul 2009 01:44
Last Modified:11 Mar 2011 08:57

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1.Bancroft J. The biological basis of human sexuality. In: Human Sexuality and its problems. Edinburgh: Churchill LIvingstone; 1989:12-127.

2.Kaplan HP. The New Sex Therapy. New York, Brunner / Mazel, 1974.

3.Schiavi RC, Segraves RT. The biology of sexual function. Psychiatr Clin North Am 1995;18(1):7-23.

4.Harvey KV, Balon R. Clinical implications of antidepressant drug effects on sexual function. Ann Clin Psychiatry  1995;7:189-201.

5.Hallward A, Ellison JM. Sexual dysfunction. In: Antidepressants and Sexual Function. London: Harcourt Health Communications. 2001:28-57.

6.DeGroat WC, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000;57:1012-1030.

7.Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000;57:1012-1030.

8.Creed K, Carati CJ, Keogh EJ. The physiology of penile erection. Rev Reproduct Biol 1991;13:73-95.

9.Levin RJ. The mechanism of female and arousal. Ann Rev Sex Res 1992;3:1-48.

10.Exton NG, Truong TC, Exton MS et. al., Neuroendocrine response to file-induced sexual arousal in men and women. Psychoneuroendocrinol 2000;25(2):187-9.

11.Bartlik B. Recent developments in the evaluation and treatment of sexual disorders in women. Psychiatr Ann 1999;29(1):60-62

12.O'Carroll R, Shapiro C, Bancroft J. Androgens, behaviour and nocturnal erection in hypogonadal men: the effect of varying the replacement dose. Clin Endocrinol 1985;23:527-538.

13.Alexander GM, Swerdloff RS, Wang CW, Davidson T. Androgen- behaviour correlations in hypogonadal men and eugonadal men, I: Mood and response to auditory sexual stimuli. Horm Behav 1997;31:110-119.

14.Schiavi RC, White D. Androgen and male sexual function: A review of human studies. J Sex Maritial Ther 1976;2:214-218.

15.O'Carrol RE, Bancroft J. Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study. Br J Psychiatry 1984;145:146-151.

16.Waxenberg SE, Drellich MG, Sutherland AM. The role of hormones in human behaviour, I: Changes in female sexuality after adrenalectomy. J Clin Endocrinol 1959;19:193-202.

17.Sherwin B. Changes in sexual behaviour as a function of plasma sex steroid levels in post-menopansal women. Maturitas 1985;7:225-233.

18.Cooper AJ. Progestogen in the treatment of male sex offenders: a review. Can J Psychiatry 1986;31:73-79.

19.Bancroft J, Tennent G, Loucas K, Cass J. The control of deviant sexual behaviour by drugs, I: behavioural changes following oestrogen and antiandrogens. Br J Psychiatry 1974;125:310-315.

20.Dennerstein L, Gotts G, Brown JB, Morse CA, Farley TM, Pinol A. The relationship between the menstrual cycle and female sexual interest in women with PMS complaints and volunteers. Psychoneuroendocrinology 1994;19:293-304.

21.Nathorst-Boos J, Von Schoultz B, Carlstrom K. Elective ovarian removal and oestrogen replacement therapy: effects on sexual life, psychological well being and androgen status. J Psychosom Obstet Gynaecol 1993;14:283-293.

22.Sherwin B. The psychoendocrinology of aging and female sexuality. Annu Rev Sex Res 1991;2:181-198.

23.Heller CG, Laidlaw WM, Harvey HT, Nelson WO. Effects of progestational compounds on the reproductive phases of the human male. Ann NY Acad Sci 1958;71:649-665.

24.Money J. Use of an androgen depleting hormone in the treatment of male sex offenders. J Sex Res 1970;6:165-172.

25.Kane FJ, Lipton MA, Ewing JA. Hormonal influences in female sexual response. Arch Gen Psychiatry 1979;20:202-209.

26.Warner P, Bancroft J. Mood, sexuality, oral contraceptives and the menstrual cycle. J Psychosom Res 1988;32:417-427.

27.Furuhjelm M, Karlgren E, Carlstrom K. The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women. Acta Obstet Gynecol Scand 1984;63:655-661.

28.Studd JWW, Collins WP, Chakravarti S, Newton JR, Oram D, Parsons A. Oestradiol and testosterone implants in the treatments of psychosexual problems in the postmenopausal women. Br J Obstet Gynaecol 1977;84:314-315.

29.Dornan WA, Malsbury CW. Neuropeptides and male sexual behaviour. Neurosci Biobehav Rev 1989;13:1-15.

30.Gooren L. Preliminary evidence that not prolactin itself, but the underlying dopaminergic dysregulation causes male sexual dysfunction in the cases of hyperprolactinemia. Paper presented at: International Academy of Sex Research, August 16, 1986; Amsterdam, the Netherlands.

31.Legros J, Mormot C, Servalis J. A psychoendocrine study of erectile psychogenic impotence: a comparison between normal patients and patients with abnormal glucose tolerance test. In Carenza L, Pancheri P, Zichella L, eds. Clinical Psychoneuroendocrinology and Reproduction. New York, NY: Academic Press Inc; 1992:301-319.

32.Deutsch S, Sherman L. Hypoprolactinemia in men with secondary sexual impotence and men with premature ejaculation. In: Endocrinology Society Meeting Abstracts. New York, NY: Endocrinology Society. 1979:350.

33.Muller P, Musch K, Wolf AS. Prolactin variables in personality and sexual behaviour. In Zichella L, Pancheri P, eds. Psychoneuroendocrinology in Reproduction. Amsterdam, the Netherlands: Elsevier / North – Holland. Biomedical Press. 1979:359-372.

34.Blaicher W, Gruber D, Bieglmayer C, Blaicher AM, Knogler W, Huber JC. The role of oxytocin in relation to female sexual arousal. Gynecol Obstet Invest 1999;47:125-126.

35.Carmichael MS, Warbuton VL, Dixen J, Davidson JM. Relationships among cardiovascular muscular and oxytocin responses during human sexual activity. Arch Sex Behav 1994;23:59-77.

36.Granata A, Bancroft J, Del Rio G. Stress and the erectile response to intracavernosal  prostaglandin E1 in men with erectile dysfunction. Psychosom Med 1995;57:336-344.

37.Culter WB, Friedman E, McCoy NL. Pheromonal influences on sociosexual behaviour in men. Arch Sex Behav 1998;27:1-13.

38.Andersson KE, Hedlund P, Alm P. Sympathetic pathways and adrenergic innervation of the penis. Int J Impot Res 2000;12(S1):S5-S12.

39.Burnett AL. Role of nitric oxide in the physiology of erection. Biol Reprod 1995;52:485-489.

40.Burnett AL, Calvin DC, Silver RI, Peppas DS, Docimo SG. Immunohistochemical description of nitric oxide synthase isoforms in human clitoris. J Urol 1997;158:75-78.

41.Beavo JA. Cyclic nucleotide phosphodiestrases: functional implications of multiple isoforms. Physiol Rev 1995;75:725-748.

42.Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999;19:67-85.

43.Zajecka K. Strategies for the treatment of antidepressant related sexual dysfunction. J Clin Psychiatry 2001;62(suppl 13):35-43.

44.Bitran D, Hull EM. Pharmacological analysis of male rat sexual behaviour. Neurosci Biobehav Rev 1987;11:365–389.

45.Zajecka J, Fawcett J, Schaff M, Jeffriess H, Guy C. The role of serotonin in sexual dysfunction: fluoxetine associated orgasm dysfunction. J Clin Psychiatry 1991;52(2):66-8.

46.Melis MR, Argiolas A. Dopamine and sexual behaviour. Neurosci Biobehav Rev 1995;19:19-38.

47.Foreman MM, Moss RL. Role of hypothalamic dopaminergic receptors in the control of lordosis behaviour in the female rat. Physiol Behav 1979;22:283-9.

48.Bartels A, Zeki S. The neural basis of romantic love. Neuroreport 2000;11(17):3829-34.

49.Exton MS, Bindert A, Kruger T, Scheller F, Hartmann U, Schedlowski M. Cardiovascular and endocrine alterations after masturbation induced orgasm in women. Psychosom Med 1999;61:280-289.

50.Ende N, Gertner SB, Hwang SG, Kadi RS. Measurement of postcoital sympathetic activity in females by means of vanillyl mandelic acid. Horm Behav 1989;23:150-156.

51.Kruger J, Exton MS, Pawlak C, Vonzur Muhlen A, Hartmann U, Shedlowski M. Neuroendocrine and Cardiovascular response to sexual arousal and orgasm in men. Psychoneuroendocrinology 1998;23:401-411.

52.Wiedeking C, Ziegler MG, Lake CR. Plasma noradrenaline and dopamine beta-hydroxylase during human sexual activity. J. Psychiatr Res 1979;15:139-145.

53.Blanco, Saenzde Tejada I, Goldstein I, Krane RJ, Wotiz HH, Cohen RA. Cholinergic neurotransmission in human corpus cavernosum II: acetylcholine synthesis. Am J Physio 1988; 254: H468-H472.

54.Godec CJ, Bates H. Cholinergic receptors in corpus caversnosa. Urology 1984;24:31-33.

55.Crenshaw TL, Goldberg JP. Drugs that affect sexual functioning. In: Sexual Pharmacology. New York: WW Norton & Company; 1996:307-16.

56.Cara AM, Lopes-Martins RAB, Antunes E, Nahoum CRD, Nucci DE. The role of histamine in human penile erection. Br J Urol 1995;75:220-224.

57.Galbraith RA, Michnovicz JJ. The effects of cimetidine on the oxidative metabolism of estradiol. N Eng J Med 1989;321(5):269-74.

58.Gitlin MJ. Psychotropic Medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry 1994;55(9):406-13.

59.Baldwin DS, Birtwistle J. Antidepressant drugs and sexual function: Improving the recognition and management of sexual dysfunction in depressed patients. In Briley M, Montgomery S (eds). Antidepressant therapy at the dawn of the third millennium. London: Martin Dunitz, 1998, 231-53.

60.Hallward A, Ellison JM. The physiology of sexual function. In Antidepressants and sexual function. London: Harcourt Health Communications; 2001;8-27.


Repository Staff Only: item control page